The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non-Hodgkin lymphoma

Rebecca Citrin; Kelly D Getz; Yimei Li; Yuan-Shung Huang; Joseph P Horowitz; Alix E Seif; Brian T Fisher; Richard Aplenc

doi:10.1111/bjh.15159

The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non-Hodgkin lymphoma

Br J Haematol. 2019 Feb;184(4):684-688. doi: 10.1111/bjh.15159. Epub 2018 Apr 2.

Authors

Rebecca Citrin¹, Kelly D Getz^{1

2}, Yimei Li^{1

3

4}, Yuan-Shung Huang², Joseph P Horowitz⁵, Alix E Seif^{1

4}, Brian T Fisher^{3

2

4

6}, Richard Aplenc^{1

3

2

4}

Affiliations

¹ Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
² Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
³ Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
⁴ Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
⁵ Drexel University College of Medicine, Philadelphia, PA, USA.
⁶ Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

No abstract available

Keywords: hyperuricaemia; non-Hodgkin lymphoma, acute leukaemia; rasburicase; tumour lysis syndrome..

Publication types

Clinical Trial
Letter
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Child
Child, Preschool
Humans
Infant
Lymphoma, Non-Hodgkin / drug therapy*
Lymphoma, Non-Hodgkin / epidemiology*
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / epidemiology*
Retrospective Studies
Urate Oxidase / administration & dosage*
Urate Oxidase / adverse effects

Substances

rasburicase
Urate Oxidase

Publication types

MeSH terms

Substances

Grants and funding